139 related articles for article (PubMed ID: 24629698)
21. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
22. Role of fibulin-1 gene promoter methylation in the carcinogenesis and development of tongue squamous cell carcinoma.
Yang F; Shi J; Zhang L; Wang H; Li Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Apr; 133(4):432-440. PubMed ID: 35153187
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma.
Shang ZJ; Ethunandan M; Górecki DC; Brennan PA
Oral Oncol; 2008 Dec; 44(12):1139-46. PubMed ID: 18487074
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
25. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.
Li S; Jiao J; Lu Z; Zhang M
Oncol Rep; 2009 May; 21(5):1223-33. PubMed ID: 19360298
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
27. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells.
Jhaveri MS; Morrow CS
Gene; 1998 Mar; 210(1):1-7. PubMed ID: 9524203
[TBL] [Abstract][Full Text] [Related]
28. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
[TBL] [Abstract][Full Text] [Related]
29. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
33. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
34. Correlation between CCR7 expression and lymph node metastatic potential of human tongue carcinoma.
Xia X; Liu K; Zhang H; Shang Z
Oral Dis; 2015 Jan; 21(1):123-31. PubMed ID: 24528991
[TBL] [Abstract][Full Text] [Related]
35. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
36. Association of RUNX3 Methylation with Clinical Outcome and Cell Migration/Invasion in Laryngeal Squamous Cell Carcinoma.
Liu ZH; Liu JJ; Li SS; Yang XM
Cancer Invest; 2016; 34(2):105-13. PubMed ID: 26853927
[TBL] [Abstract][Full Text] [Related]
37. Wnt7a predicts poor prognosis, and contributes to growth and metastasis in tongue squamous cell carcinoma.
Jia B; Qiu X; Chu H; Sun X; Xu S; Zhao X; Zhao J
Oncol Rep; 2019 Mar; 41(3):1749-1758. PubMed ID: 30747225
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G
Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896
[TBL] [Abstract][Full Text] [Related]
39. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ
World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434
[TBL] [Abstract][Full Text] [Related]
40. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma.
Liu L; Zhang S; Liu X; Liu J
Mol Med Rep; 2019 Apr; 19(4):3273-3282. PubMed ID: 30816454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]